Legal & General Group
DGX icon

Legal & General Group’s Quest Diagnostics DGX Stock Holding History

Legal & General Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$144M Sell
736,625
-6,349
-0.9% -$1.23M 0.03% 423
2025
Q4 		$129M Sell
742,974
-12,701
-2% -$2.31M 0.03% 456
2025
Q3 		$144M Buy
755,675
+22,070
+3% +$3.92M 0.03% 439
2025
Q2 		$132M Sell
733,605
-25,191
-3% -$4.38M 0.03% 447
2025
Q1 		$128M Buy
758,796
+14,022
+2% +$2.3M 0.04% 442
2024
Q4 		$112M Sell
744,774
-26,195
-3% -$4.07M 0.03% 480
2024
Q3 		$120M Sell
770,969
-603
-0.1% -$90.1K 0.03% 475
2024
Q2 		$106M Sell
771,572
-33,584
-4% -$4.6M 0.03% 471
2024
Q1 		$107M Sell
805,156
-44,245
-5% -$5.74M 0.03% 479
2023
Q4 		$117M Sell
849,401
-77,755
-8% -$10.2M 0.04% 445
2023
Q3 		$113M Sell
927,156
-26,344
-3% -$3.51M 0.04% 440
2023
Q2 		$134M Sell
953,500
-1,825
-0.2% -$252K 0.04% 411
2023
Q1 		$135M Sell
955,325
-104,476
-10% -$14.9M 0.05% 398
2022
Q4 		$166M Sell
1,059,801
-76,926
-7% -$11.1M 0.06% 347
2022
Q3 		$139M Sell
1,136,727
-103,316
-8% -$13.6M 0.05% 378
2022
Q2 		$165M Buy
1,240,043
+55,298
+5% +$7.54M 0.06% 358
2022
Q1 		$162M Buy
1,184,745
+108,691
+10% +$15.1M 0.05% 407
2021
Q4 		$186M Sell
1,076,054
-56,093
-5% -$8.53M 0.06% 369
2021
Q3 		$165M Buy
1,132,147
+36,030
+3% +$5.27M 0.05% 398
2021
Q2 		$145M Buy
1,096,117
+62,112
+6% +$8.13M 0.05% 421
2021
Q1 		$133M Buy
1,034,005
+25,750
+3% +$3.17M 0.05% 413
2020
Q4 		$120M Buy
1,008,255
+27,568
+3% +$3.36M 0.05% 419
2020
Q3 		$112M Sell
980,687
-8,416
-0.9% -$994K 0.05% 387
2020
Q2 		$113M Sell
989,103
-262,819
-21% -$27.9M 0.05% 375
2020
Q1 		$101M Buy
1,251,922
+72,417
+6% +$7.5M 0.06% 348
2019
Q4 		$126M Buy
1,179,505
+13,455
+1% +$1.4M 0.06% 356
2019
Q3 		$125M Buy
1,166,050
+5,275
+0.5% +$542K 0.07% 329
2019
Q2 		$118M Buy
1,160,775
+57,827
+5% +$5.56M 0.06% 356
2019
Q1 		$99.2M Buy
1,102,948
+154,986
+16% +$13.4M 0.06% 374
2018
Q4 		$78.9M Buy
947,962
+99,115
+12% +$9.29M 0.06% 350
2018
Q3 		$91.6M Buy
848,847
+77,204
+10% +$8.47M 0.07% 324
2018
Q2 		$84.8M Sell
771,643
-33,778
-4% -$3.52M 0.07% 332
2018
Q1 		$80.8M Sell
805,421
-4,673
-0.6% -$479K 0.06% 343
2017
Q4 		$79.8M Sell
810,094
-28,711
-3% -$2.72M 0.06% 355
2017
Q3 		$78.5M Buy
838,805
+22,408
+3% +$2.38M 0.06% 348
2017
Q2 		$90.8M Buy
816,397
+33,464
+4% +$3.54M 0.07% 303
2017
Q1 		$76.9M Buy
782,933
+39,143
+5% +$3.73M 0.07% 329
2016
Q4 		$68.4M Sell
743,790
-1,899
-0.3% -$164K 0.06% 333
2016
Q3 		$63.1M Buy
745,689
+7,300
+1% +$613K 0.06% 331
2016
Q2 		$60.1M Buy
738,389
+22,110
+3% +$1.68M 0.06% 332
2016
Q1 		$51.2M Buy
716,279
+13,937
+2% +$935K 0.06% 357
2015
Q4 		$50M Sell
702,342
-608
-0.1% -$40.9K 0.06% 370
2015
Q3 		$43.2M Buy
702,950
+24,207
+4% +$1.69M 0.05% 392
2015
Q2 		$49.2M Sell
678,743
-5,979
-0.9% -$441K 0.06% 370
2015
Q1 		$52.6M Sell
684,722
-6,611
-1% -$473K 0.06% 350
2014
Q4 		$46.4M Sell
691,333
-4,943
-0.7% -$312K 0.05% 385
2014
Q3 		$42.3M Sell
696,276
-8,788
-1% -$542K 0.05% 417
2014
Q2 		$41.4M Buy
705,064
+27,727
+4% +$1.62M 0.05% 433
2014
Q1 		$39.2M Sell
677,337
-920
-0.1% -$49.3K 0.05% 428
2013
Q4 		$36.3M Sell
678,257
-12,719
-2% -$754K 0.04% 446
2013
Q3 		$42.7M Sell
690,976
-3,320
-0.5% -$199K 0.06% 380
2013
Q2 		$42.1M Buy
+694,296
New +$41.4M 0.06% 373

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Legal & General Group's DGX Position: Q1 2026 in Review

Legal & General Group reduced its Quest Diagnostics (DGX) stake by 0.85% in Q1 2026, selling an estimated $1.23M and leaving 736,625 shares worth $144M. The position accounts for 0.03% of the portfolio, ranked #423.

Legal & General Group first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $186M in Q4 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Legal & General Group held 736,625 shares of Quest Diagnostics worth $144M as of Q1 2026.
  • Legal & General Group sold 6,349 Quest Diagnostics shares in Q1 2026, an estimated $1.23M.
  • Quest Diagnostics made up 0.03% of Legal & General Group's portfolio in Q1 2026, its #423 holding.
  • Legal & General Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Legal & General Group's Quest Diagnostics position peaked at $186M in Q4 2021.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.